logo.jpg
Codexis Senior Vice President of R&D Dr. Jim Lalonde Announces Plan to Resign
April 05, 2019 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., April 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that Jim Lalonde, Ph.D., Senior Vice President of Research and...
RND logo.PNG
Dietary Supplements Market To Reach USD 210.3 Billion By 2026 | Reports And Data
March 25, 2019 12:43 ET | Reports And Data
Preventive health care, new product launches, increasing strategic developments such as partnerships and agreements, favorable research funding scenario, and new product development pressure on...
RND logo.PNG
Food Ingredients Market to Reach USD 63.11 Billion By 2026 | Reports And Data
March 21, 2019 12:35 ET | Reports And Data
The growth of the market is driven by the global expansion in the processed foods market and the increasing demand from developing economies. Market Size – USD 33.67 billion in 2018, Market Growth -...
logo.jpg
Codexis to Participate in Two Investment Conferences in March
March 05, 2019 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in two upcoming investment...
logo.jpg
Codexis Reports 2018 Fourth Quarter and Full Year Financial Results
February 26, 2019 16:05 ET | Codexis, Inc.
2018 revenues of $61 million include a 50% increase in R&D revenue Introduces 2019 financial guidance Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available...
logo.jpg
Codexis Names Laurie Heilmann Senior Vice President of Business Development and Marketing
February 25, 2019 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Laurie Heilmann to Senior Vice President of...
logo.jpg
Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26
February 19, 2019 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2018 fourth quarter and full year financial...
logo.jpg
Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria
February 14, 2019 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that Nestlé Health Science has exercised its option to obtain...
Codexis logo - 110117 jpg.jpg
Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan
February 06, 2019 07:00 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for the supply of a...
Codexis logo - 110117 jpg.jpg
Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck
February 04, 2019 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the signing of a new agreement with Merck, through a...